Free Trial

Phibro Animal Health (PAHC) Stock Price, News & Analysis

+0.12 (+0.69%)
(As of 07/15/2024 ET)
Today's Range
50-Day Range
52-Week Range
131,619 shs
Average Volume
142,609 shs
Market Capitalization
$712.80 million
P/E Ratio
Dividend Yield
Price Target

Phibro Animal Health MarketRank™ Stock Analysis

Analyst Rating
1.75 Rating Score
16.2% Downside
$14.75 Price Target
Short Interest
2.15% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.94mentions of Phibro Animal Health in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From $1.13 to $1.42 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.84 out of 5 stars

Medical Sector

214th out of 913 stocks

Pharmaceutical Preparations Industry

94th out of 432 stocks

PAHC stock logo

About Phibro Animal Health Stock (NASDAQ:PAHC)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

PAHC Stock Price History

PAHC Stock News Headlines

Phibro Animal Health (NASDAQ:PAHC) Trading Down 3.9%
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
This student turned $1,300 into $45,000 in just 4 Months!
With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 6/26 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Pharmaceutical Products
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
4 Analysts


Net Income
$32.61 million
Pretax Margin


Sales & Book Value

Annual Sales
$977.90 million
Cash Flow
$2.09 per share
Book Value
$6.97 per share


Free Float
Market Cap
$716.04 million
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Jack Clifford BendheimMr. Jack Clifford Bendheim (Age 77)
    Chairman, President & CEO
    Comp: $2.9M
  • Mr. Larry L. Miller (Age 60)
    Chief Operating Officer
    Comp: $774.91k
  • Mr. Daniel M. Bendheim (Age 52)
    Executive VP of Corporate Strategy & Director
    Comp: $548.18k
  • Mr. Rob Aukerman (Age 66)
    President of North America Region
    Comp: $619.27k
  • Mr. Glenn C. David (Age 51)
    Chief Financial Officer
  • Ms. Judith A. Weinstein (Age 55)
    Senior VP, General Counsel & Corporate Secretary
  • Ms. Lisa A. Escudero (Age 62)
    Senior Vice President of Human Resources
  • Mr. Jonathan Bendheim (Age 48)
    President of MACIE Region, GM of Israel Operations & Director
  • Mr. Ramon Fuenmayor
    President South America Region
  • Mr. Samson Li (Age 52)
    President of Asia Pacific Region

PAHC Stock Analysis - Frequently Asked Questions

How have PAHC shares performed this year?

Phibro Animal Health's stock was trading at $11.58 at the beginning of the year. Since then, PAHC shares have increased by 52.0% and is now trading at $17.60.
View the best growth stocks for 2024 here

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) announced its quarterly earnings data on Wednesday, May, 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.02. The business had revenue of $263.20 million for the quarter, compared to analysts' expectations of $251.82 million. Phibro Animal Health had a trailing twelve-month return on equity of 17.11% and a net margin of 1.32%.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's top institutional investors include Cardinal Capital Management (0.14%) and CWM LLC (0.01%).
View institutional ownership trends

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT) and VIVUS (VVUS).

This page (NASDAQ:PAHC) was last updated on 7/15/2024 by Staff

From Our Partners